Literature DB >> 31203694

Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.

Paul R Ortiz de Montellano1.   

Abstract

The oxidation of carbon-carbon triple bonds by cytochrome P450 produces ketene metabolites that are hydrolyzed to acetic acid derivatives or are trapped by nucleophiles. In the special case of 17α-ethynyl sterols, D-ring expansion and de-ethynylation have been observed as competing pathways. The oxidation of acetylenic groups is also associated with mechanism-based inactivation of cytochrome P450 enzymes. One mechanism for this inactivation is reaction of the ketene metabolite with cytochrome P450 residues essential for substrate binding or catalysis. However, in the case of monosubstituted acetylenes, inactivation can also occur by addition of the oxidized acetylenic function to a nitrogen of the heme prosthetic group. This addition reaction is not mediated by the ketene metabolite, but rather occurs during oxygen transfer to the triple bond. In some instances, a detectable intermediate is formed that is most consistent with a ketocarbene-iron heme complex. This complex can progress to the N-alkylated heme or revert back to the unmodified enzyme. The ketocarbene complex may intervene in the formation of all the N-alkyl heme adducts, but is normally too unstable to be detected.

Entities:  

Keywords:  Acetylene oxidation; cytochrome P450 inactivation; ethynylsterols; iron–carbene complexes; ketene formation; oxirene

Mesh:

Substances:

Year:  2019        PMID: 31203694      PMCID: PMC6699906          DOI: 10.1080/03602532.2019.1632891

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  101 in total

1.  Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.

Authors:  Hsia-lien Lin; Haoming Zhang; Matthew J Pratt-Hyatt; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-09-19       Impact factor: 3.922

2.  Biotransformation of 4'-ethynl-2-fluorobiphenyl in the rat. In vitro and in vivo studies.

Authors:  H R Sullivan; P Roffey; R E McMahon
Journal:  Drug Metab Dispos       Date:  1979 Mar-Apr       Impact factor: 3.922

3.  Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.

Authors:  K A Regal; M L Schrag; U M Kent; L C Wienkers; P F Hollenberg
Journal:  Chem Res Toxicol       Date:  2000-04       Impact factor: 3.739

4.  Metabolic oxidation of the ethynyl group in 4-ethynylbiphenyl.

Authors:  A Wade; A M Symons; L Martin; D V Parke
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

5.  The catalytic site of rat hepatic lauric acid omega-hydroxylase. Protein versus prosthetic heme alkylation in the omega-hydroxylation of acetylenic fatty acids.

Authors:  C A CaJacob; W K Chan; E Shephard; P R Ortiz de Montellano
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

6.  Self-catalyzed inactivation of hepatic cytochrome P-450 by ethynyl substrates.

Authors:  P R Ortiz de Montellano; K L Kunze
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

7.  Theoretical Insights into the Mechanism and Stereoselectivity of Olefin Cyclopropanation Catalyzed by Two Engineered Cytochrome P450 Enzymes.

Authors:  Hao Su; Guangcai Ma; Yongjun Liu
Journal:  Inorg Chem       Date:  2018-08-29       Impact factor: 5.165

8.  2-ethynylnaphthalene as a mechanism-based inactivator of the cytochrome P-450 catalyzed N-oxidation of 2-naphthylamine.

Authors:  G J Hammons; W L Alworth; N E Hopkins; F P Guengerich; F F Kadlubar
Journal:  Chem Res Toxicol       Date:  1989 Nov-Dec       Impact factor: 3.739

9.  Acetylenic mechanism-based inhibitors of cholesterol side chain cleavage by cytochrome P-450scc.

Authors:  A Nagahisa; R W Spencer; W H Orme-Johnson
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.

Authors:  E S Roberts; N E Hopkins; E J Zaluzec; D A Gage; W L Alworth; P F Hollenberg
Journal:  Arch Biochem Biophys       Date:  1995-11-10       Impact factor: 4.013

View more
  1 in total

Review 1.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.